SPDR Tech ETF (XNTK) returned 717% over the past decade versus 501% for QQQ. XNTK caps each position at 4.50%. XNTK charges a 0.35% expense ratio. Equal-weighting in semiconductors creates amplified ...

Add Yahoo as a preferred source to see more of our stories on Google. Kelly Osbourne has made headlines for her dramatic weight loss after sharing a series of photos online that highlight her ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of proteins—sit at the heart of some of the most successful medicines ever created, from ...

JD Vance has clarified he is not Donald Trump's "fat" friend using weight-loss drugs to shed the pounds, RadarOnline.comcan reveal. During a cabinet meeting, Vance made sure to interject and explain ...

Choose Chicago President and CEO Kristen Reynolds joins Bob Sirott to talk about the progress of Chicago’s businesses in the Loop post-COVID and how you can learn more about the city’s architecture ...

SHANGHAI—Hundreds of vendors at Shanghai’s largest clothing market were very busy. But they weren’t making sales. They were processing returns. At Qipu Road Wholesale Clothing Market, wholesalers send ...

Seeing The Weight, which had its world premiere tonight at the Sundance Film Festival, it so reminded me of the kind of solid adventure picture studios used to lure major stars to make, and also the ...

JAKARTA, Jan 26 (Reuters) - The death toll from a landslide that hit Indonesia's West Java province at the weekend rose to 17 on Monday, the country's disaster mitigation agency said, with dozens ...

Last week’s announcement by Sam Chun Dang Pharm that it will jointly develop and commercialize a weight-loss pill, with Japanese drug maker Daiichi Sankyo, fueled a rally in the Korean company’s ...

As a recent thought-provoking article by New York Times writer Lisa Miller described one couple, Jeanne and Javier: “She expected her body to change when she started taking Zepbound. But nobody told ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...